|
ABLIM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.086700198362E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.4487000488117E-09 |
| Normal-vs-Stage2 |
1.21159999810772E-08 |
| Normal-vs-Stage3 |
2.14219997296539E-09 |
| Normal-vs-Stage4 |
7.32760518928899E-11 |
| Stage1-vs-Stage2 |
8.789000E-01 |
| Stage1-vs-Stage3 |
8.490200E-01 |
| Stage1-vs-Stage4 |
6.026500E-02 |
| Stage2-vs-Stage3 |
7.971800E-01 |
| Stage2-vs-Stage4 |
1.324190E-01 |
| Stage3-vs-Stage4 |
1.566620E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.48719983181923E-10 |
| Normal-vs-AfricanAmerican |
1.24430000003617E-06 |
| Normal-vs-Asian |
2.84740000466854E-08 |
| Caucasian-vs-AfricanAmerican |
3.322200E-01 |
| Caucasian-vs-Asian |
7.431600E-01 |
| AfricanAmerican-vs-Asian |
5.794000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.78529976860398E-10 |
| Normal-vs-Female |
1.47879997136613E-09 |
| Male-vs-Female |
2.024400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.96569998851027E-09 |
| Normal-vs-Age(41-60Yrs) |
1.09560005512321E-09 |
| Normal-vs-Age(61-80Yrs) |
1.65769953319739E-10 |
| Normal-vs-Age(81-100Yrs) |
4.1899999999595E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.119000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.576200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.769420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.292400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.402000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.707800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.786400E-01 |
| Classical-VS-Follicular |
1.140600E-01 |
| Classical-VS-Other |
7.521000E-01 |
| Classical-VS-Normal |
3.69329999916346E-09 |
| Tall-VS-Follicular |
2.312600E-01 |
| Tall-VS-Other |
7.285000E-01 |
| Tall-VS-Normal |
1.63650000217785E-08 |
| Follicular-VS-Other |
4.688400E-01 |
| Follicular-VS-Normal |
4.7724002527616E-10 |
| Other-VS-Normal |
1.828420E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.50130027801276E-10 |
| Normal-vs-N1 |
1.12830000897901E-09 |
| N0-vs-N1 |
9.127200E-01 |
|
|
